BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils von Smiljkovic, D., Blatt, K., Stefanzl, G., Dorofeeva, Y., Skrabs, C., Focke‐Tejkl, M., Sperr, W. R., Jaeger, U., Valenta, R., Valent, P.

Volltext

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib von Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, P B, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, C-M, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U

Volltext

Rapid decline in insulin antibodies and glutamic acid decarboxylase autoantibodies with ibrutinib therapy of chronic lymphocytic leukaemia von Skrabs, C., Pickl, W. F., Perkmann, T., Jäger, U., Gessl, A.

Volltext

Molecular classification of tumour cells in a patient with intravascular large B‐cell lymphoma von Bauer, W.M., Aichelburg, M.C., Griss, J., Skrabs, C., Simonitsch‐Klupp, I., Schiefer, A.I., Kittler, H., Jäger, U., Zeyda, M., Knobler, R., Stingl, G.

Volltext

Autoimmune thrombocytopenia in non-Hodgkin's lymphomas von Hauswirth, Alexander W, Skrabs, Cathrin, Schutzinger, Christian, Raderer, Markus, Chott, Andreas, Valent, Peter, Lechner, Klaus, Jager, Ulrich

Volltext

MALT lymphoma in patients with autoimmune diseases : a comparative analysis of characteristics and clinical course von WOHRER, S, TROCH, M, RADERER, M, STREUBEL, B, ZWERINA, J, SKRABS, C, FORMANEK, M, HAUFF, W, HOFFMANN, M, MÜLLAUER, L, CHOTT, A

Volltext

Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma von Gebhart, J, Lechner, K, Skrabs, C, Sliwa, T, Müldür, E, Ludwig, H, Nösslinger, T, Vanura, K, Stamatopoulos, K, Simonitsch-Klupp, I, Chott, A, Quehenberger, P, Mitterbauer-Hohendanner, G, Pabinger, I, Jäger, U, Geissler, K

Volltext

UNMAINTAINED REMISSION AFTER DISCONTINUATION OF KINASE INHIBITOR TREATEMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA: AN OBSERVATIONAL COHORT von Egle, A., Jäger, U., Skrabs, C., Dürig, J., Nösslinger, T., Wanner, D., Steurer, M., Ringshausen, I., Melchardt, T., Greil, R., Ysebaert, L.

Volltext

Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients von Fiegl, M., Stauder, R., Steurer, M., Mian, M., Hopfinger, G., Brychtova, Y., Skrabs, C., Zabernigg, A., Schmid, F., Haslbaur, F., Winder, G., Walder, A., Lang, A., Voskova, D., Greil, R., Mayer, J., Gastl, G.

Volltext

Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an 'angiocentric' histological morphology von Pfistershammer, K., Petzelbauer, P., Stingl, G., Mastan, P., Chott, A., Jäger, U., Skrabs, C., Geusau, A.

Volltext

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial von Jaeger, Ulrich, Trneny, Marek, Melzer, Helen, Praxmarer, Michael, Nawarawong, Weerasak, Ben Yehuda, Dina, Goldstein, David, Mihaljevic, Bilijana, Ilhan, Osman, Ballova, Veronika, Hedenus, Michael, Hsiao, Liang-Tsai, Au, Wing-Yan, Burgstaller, Sonja, Weidinger, Gerhard, Keil, Felix, Dittrich, Christian, Skrabs, Cathrin, Klingler, Anton, Chott, Andreas, Fridrik, Michael A, Greil, Richard

Volltext

Treatment of HBV-carrying lymphoma patients with Rituximab and CHOP: a diagnostic and therapeutic challenge von Skrabs, C, Müller, C, Agis, H, Mannhalter, C, Jäger, U

Volltext

Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response von JÄGER, Ulrich, FRIDRIK, Michael, EINBERGER, Christine, DRACH, Johannes, RADERER, Markus, GAIGER, Alexander, PUTMAN, Monique, GREIL, Richard, ZEITLINGER, Markus, HEINTEL, Daniel, HOPFINGER, Georg, BURGSTALLER, Sonja, MANNHALTER, Christine, OBERAIGNER, Wilhelm, PORPACZY, Edit, SKRABS, Cathrin

Volltext

Influence of rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone on serologic parameters and clinical course in lymphoma patients with autoimmune diseases von Wöhrer, S, Troch, M, Zwerina, J, Schett, G, Skrabs, C, Gaiger, A, Jaeger, U, Zielinski, CC, Raderer, M

Volltext

Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome von Simonitsch-Klupp, I, Hauser, I, Ott, G, Drach, J, Ackermann, J, Kaufmann, J, Weltermann, A, Greinix, H T, Skrabs, C, Dittrich, C, Lutz, D, Pötter, R, Mannhalter, C, Lechner, K, Chott, A, Jaeger, U

Volltext

Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL) von MITTERBAUER-HOHENDANNER, G, MANNHALTER, C, WINKER, K, MITTERBAUER, M, SKRABS, C, CHOTT, A, SIMONITSCH-KLUPP, I, GLEISS, A, LECHNER, K, JAEGER, U

Volltext

Pautrier microabscesses (PA): a historical note von Schmidt-Skrabs, C C

Volltext

Cyclin D3 Is a Predictive and Prognostic Factor in Diffuse Large B-cell Lymphoma von FILIPITS, Martin, JAEGER, Ulrich, POHL, Gudrun, STRANZL, Thomas, SIMONITSCH, Ingrid, KAIDER, Alexandra, SKRABS, Cathrin, PIRKER, Robert

Volltext

Autoimmune conditions and chronic infections in chronic lymphocytic leukemia patients at diagnosis are associated with unmutated IgVH genes von Vanura, Katrina, Le, Trang, Esterbauer, Harald, Spath, Florentin, Porpaczy, Edit, Shehata, Medhat, Eigenberger, Karin, Hauswirth, Alexander, Skrabs, Cathrin, Kromer, Elisabeth, Schwarzinger, Ilse, Streubel, Berthold, Steininger, Christoph, Fonatsch, Christa, Stilgenbauer, Stephan, Wagner, Oswald, Gaiger, Alexander, Jager, Ulrich

Volltext

Methotrexate-induced primary cutaneous diffuse large B-cell lymphoma with an ‘angiocentric’ histological morphology: Methotrexate-induced primary cutaneous large B-cell lymphom... von Pfistershammer, K., Petzelbauer, P., Stingl, G., Mastan, P., Chott, A., Jäger, U., Skrabs, C., Geusau, A.

Volltext